Tegafur derivative containing 1,3,4-thiadiazole heterocyclic ring and amide group
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of amide groups and tegafur, which is applied in the field of tegafur derivatives, can solve the problems of high toxicity and achieve the effects of reducing toxicity, enhancing lipophilicity, and low price
Inactive Publication Date: 2014-06-18
INST OF PHARMACY SHANDONG PROV ACAD OF MEDICAL SCI
View PDF3 Cites 4 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Although the compounds studied by the applicant have made progress, they still have relatively high toxicity and other deficiencies
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0019] Embodiment 1: A kind of preparation method of tegafur derivative containing 1,3,4-thiadiazole heterocycle and amide group, the steps are as follows:
[0020] ①Dissolve 3-(methoxycarbonylmethyl)tegafur in methanol, then add sodium hydroxide solution dropwise, mix sodium hydroxide and distilled water at a weight-to-volume ratio of 1:20-30 to make a solution, 45 React at ℃ for 2-4 hours, evaporate the solvent under reduced pressure, extract with ethyl acetate and distilled water to separate the organic layer and water layer, extract and combine the organic layers with water, adjust the pH value to 4, then extract with ethyl acetate, combine the organic layers, Add anhydrous sodium sulfate to dry, filter, and evaporate the solvent to obtain 1-(tetrahydro-2-furyl)-3-acetoxy-5-fluoro-2,4-pyrimidinedione;
[0021] ②Take 1-(tetrahydro-2-furyl)-3-acetoxy-5-fluoro-2,4-pyrimidinedione and dioxane, mix them in a ratio of 1:3-4 by weight and volume, and then add chlorine The volume...
Embodiment 2
[0023] Embodiment 2: A kind of preparation method of tegafur derivative containing 1,3,4-thiadiazole heterocycle and amide group, the steps are as follows:
[0024] ①Put 6.8g of 3-(methoxycarbonylmethyl)tegafur into a reaction flask, add 10ml of methanol, heat to dissolve, dissolve 1.4g of sodium hydroxide in 35ml of distilled water, add the sodium hydroxide solution dropwise, React at 45°C for 3 hours, evaporate the solvent under reduced pressure, add 50ml of distilled water and 50ml of ethyl acetate to extract and separate the organic layer and the water layer, extract the organic layer with 50 ml of water once, combine the water layers, and adjust the pH value with 10% hydrochloric acid to 4, then extracted twice with 50 ml of ethyl acetate, combined the organic layers, added 10 g of anhydrous sodium sulfate and dried for 30 minutes, filtered, and evaporated to remove the solvent to obtain 1-(tetrahydro-2-furyl)-3-acetate -5-fluoro-2,4-pyrimidinedione 4.7g, the yield is 73....
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention provides a tegafur derivative containing a 1,3,4-thiadiazole heterocyclic ring and an amide group. The structural formula of the tegafur derivative is as shown in the specification. A preparation method of the tegafur derivative comprises the steps of (1) dissolving a 3-(methoxycarbonylmethyl)tegafur in methanol, dropwise adding a sodium hydroxide solution, extracting by using ethyl acetate and distilled water and separating out an organic layer and a water layer, next, extracting by using ethyl acetate and blending the organic layers, and adding anhydrous sodium sulfate to obtain 1-(tetrahydro-2-furyl)-3-carbethoxy-5-fluoro-2,4-pyrimidinedione; (2) blending 1-(tetrahydro-2-furyl)-3-carbethoxy-5-fluoro-2,4-pyrimidinedione with dioxane, then adding sulfoxide chloride to obtain a 1-(tetrahydro-2-furyl)-3-chloracetyl-5-fluoro-2,4-pyrimidinedione solution, and then adding dioxane, evenly mixing and then sealing for later use; (3) taking 2-amino-5-p-nitrophenyl-1,3,4-thiadiazole, dioxane and triethylamine, and dropwise adding the 1-(tetrahydro-2-furyl)-3-chloracetyl-5-fluoro-2,4-pyrimidinedione solution obtained in the step (2) to obtain a pure product 1-(tetrahydro-2-furyl)-3-acetamido-[5-p-nitrophenyl-(1,3,4-thiadiazole-2-yl)]-5-fluoro-2,4-pyrimidinedione. The tegafur derivative has anti-tumor effect and no obvious toxicity, and is used for clinically treating malignant tumors.
Description
technical field [0001] The invention relates to a compound for inhibiting tumor cell proliferation, which is a tegafur derivative containing 1,3,4-thiadiazole heterocycle and amide group. Background technique [0002] Since the incidence of malignant tumors is increasing year by year, drugs to inhibit tumors have become one of the important topics studied by technicians from all over the world. Among various tumor-inhibiting compounds, 5-fluorouracil (5-Fu) is a relatively effective and safe compound, which is widely used in the treatment of various cancers. After years of clinical drug statistics, it shows that although it inhibits the proliferation of tumor cells by interfering with and blocking the synthesis of DNA, RNA and protein, 5-Fu has a short half-life and can only be administered intravenously or arterially. relatively bigger. For this reason, those skilled in the art have been studying a tegafur derivative containing 1,3,4-thiadiazole heterocycle and amide grou...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D417/14A61K31/513A61P35/00
CPCC07D417/14
Inventor 刘爱芹秦三海于胜海孙敬勇吴忠玉卢霞王延风王风玲李慧金
Owner INST OF PHARMACY SHANDONG PROV ACAD OF MEDICAL SCI
Login to view more 
Login to view more